Literature DB >> 11678428

The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children.

D N Korones1, R Butterfield, S P Meyers, L S Constine.   

Abstract

BACKGROUND: There is controversy regarding the utility of routine surveillance scanning for asymptomatic children with brain tumors. Although the role of CT or magnetic resonance imaging (MRI) scanning in this setting has been examined in several studies, none have focused on children followed exclusively by MRI. The purpose of this study was to determine how often recurrent brain tumors are detected by routine MRI surveillance in asymptomatic children.
METHODS: The medical records of all children with brain tumors treated at Children's Hospital at Strong from 1990-1999 were reviewed. Recurrence was defined as an increase in size of the tumor on MRI scan. Astrocytomas and gangliogliomas were classified as low-grade tumors; high-grade astrocytomas, medulloblastomas, and ependymomas were classified as high-grade tumors.
RESULTS: Of the 112 evaluable children with brain tumors during this time period, 46 (41%) suffered an MRI-documented recurrence. Of these 46 patients, 13 (28%) had low-grade tumors and 33 (72%) had high-grade tumors. Twenty-seven of the 46 recurrences (59%) occurred in asymptomatic children. Ten of the 13 children (77%) with recurrent low-grade tumors were asymptomatic compared to 17 of 33 children (52%) with recurrent high-grade tumors (p = 0.18). The median survival from time of recurrence for the symptomatic children was seven months, while the median survival from time of recurrence for the asymptomatic children has not yet been reached (p = 0.025). When the analysis was confined to children with high-grade tumors, there was no difference in median survival from the time of recurrence for symptomatic versus asymptomatic children (5 mo. versus 7 mo.) (p = 0.25). The frequency of detection of recurrences by surveillance scanning in asymptomatic children was 4.2% (one recurrence detected per 24 surveillence MRI scans).
CONCLUSION: The majority of recurrent brain tumors are detected by MRI surveillence in asymptomatic children. However, asymptomatic recurrences were detected in only a small proportion of surveillance scans and had no impact on survival in children with high-grade tumors.

Entities:  

Mesh:

Year:  2001        PMID: 11678428     DOI: 10.1023/a:1011804404246

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  5 in total

1.  Surveillance imaging in children with primitive neuroectodermal tumors.

Authors:  E Mendel; M L Levy; C Raffel; J G McComb; H Pikus; M D Nelson; W Ganz
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Postoperative surveillance imaging in children with cerebellar astrocytomas.

Authors:  L N Sutton; A Cnaan; L Klatt; H Zhao; R Zimmerman; M Needle; P Molloy; P Phillips
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

3.  Value of postoperative surveillance imaging in the management of children with some common brain tumors.

Authors:  P Steinbok; S Hentschel; D D Cochrane; J R Kestle
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

4.  Asymptomatic recurrence detection with surveillance scanning in children with medulloblastoma.

Authors:  D W Shaw; J R Geyer; M S Berger; J Milstein; K L Lindsley
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Surveillance scanning of children with medulloblastoma.

Authors:  C F Torres; S Rebsamen; J H Silber; L N Sutton; L T Bilaniuk; R A Zimmerman; J W Goldwein; P C Phillips; B J Lange
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

  5 in total
  7 in total

1.  Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.

Authors:  Bina Kakusa; Summer Han; Sonya Aggarwal; Boxiang Liu; Gordon Li; Scott Soltys; Melanie Hayden Gephart
Journal:  J Neurooncol       Date:  2018-11-20       Impact factor: 4.130

Review 2.  Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.

Authors:  Jasmin Jo; Martin J van den Bent; Burt Nabors; Patrick Y Wen; David Schiff
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

3.  Interval brain imaging for adults with cerebral glioma.

Authors:  Gerard Thompson; Theresa A Lawrie; Ashleigh Kernohan; Michael D Jenkinson
Journal:  Cochrane Database Syst Rev       Date:  2019-12-24

4.  Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery.

Authors:  Scott C Lester; Glen B Taksler; J Griff Kuremsky; John T Lucas; Diandra N Ayala-Peacock; David M Randolph; J Daniel Bourland; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  Cancer       Date:  2013-10-21       Impact factor: 6.921

Review 5.  The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.

Authors:  Simon P Stevens; Caroline Main; Simon Bailey; Barry Pizer; Martin English; Robert Phillips; Andrew Peet; Shivaram Avula; Sophie Wilne; Keith Wheatley; Pamela R Kearns; Jayne S Wilson
Journal:  J Neurooncol       Date:  2018-06-09       Impact factor: 4.130

6.  Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Karen Wasilewski-Masker; Qi Liu; Yutaka Yasui; Wendy Leisenring; Lillian R Meacham; Sue Hammond; Anna T Meadows; Leslie L Robison; Ann C Mertens
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 11.816

7.  The impact of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

Authors:  Caroline Main; Simon P Stevens; Simon Bailey; Robert Phillips; Barry Pizer; Keith Wheatley; Pamela R Kearns; Martin English; Sophie Wilne; Jayne S Wilson
Journal:  Syst Rev       Date:  2016-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.